If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
15.50    0.00 (0.00%)
Bid:
15.50
Ask:
15.60
Spread: 0.10 (0.645%)
Market Cap: £124.23m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

H1 Trading Update and Contract Wins

9 Jan 2012 07:00

RNS Number : 1849V
Allocate Software PLC
09 January 2012
 



 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

First Half Year Trading Update and Contract Wins

 

Allocate Software plc (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, reports the following update for the six months ended 30 November 2011.

 

Summary

 

Allocate's performance in the first half year is in line with management's expectations for the period. The pipeline of business in the UK Healthcare sector is robust and continues at recent levels with Time Care in Sweden performing well and the Australian healthcare business continuing to develop. The performance of the Defence sector is also meeting expectations.

 

Healthcare

 

Key highlights include two important acquisitions in the period: RosterOn in Australia in July and Zircadian in the UK in August.

 

Allocate was awarded 12 new contracts for HealthRoster, the e-Rostering application, of which 11 were for the NHS, increasing the total NHS e-Rostering customer base to 156 Trusts. In addition, the company won:

 

§ 1 new HealthRoster win in Malaysia / Brunei

§ 3 NHS Trusts extended their HealthRoster licences

§ 4 new customer wins for Dynamic Change

§ 6 new customer wins for Time Care

 

Defence and other markets

 

§ Post half year end, the Defence business secured a major contract with the Australian Defence Force. The agreement is a multi-year, multimillion pound license extension to its current license base that will extend the deployment of MAPS to all personnel in the Australian Army.

§ The Maritime business closed an important new order with McDermott, the leading engineering, offshore oil and gas company.

 

 

Ian Bowles, Chief Executive Officer of Allocate commented on the period:

 

"I am pleased with the momentum and performance of Allocate in this half year. We are experiencing great customer support; in addition prospective customers are selecting our applications following competitive tendering processes, to support their own business objectives. We continue to see levels of opportunities consistent with recent periods with which we are engaging. Ideally, I would prefer to see a faster closure rate on some of the NHS transactions but I am reassured by the number of prospects that are coming to market and that NHS Trusts are increasingly engaging with us to discuss their plans.

 

"The integration of both the Zircadian and RosterOn businesses is making good progress.

 

"Our overseas territories have performed well in this period. The Australian operation has benefitted from the RosterOn acquisition bringing some 17 new staff as well as its own business and customers. Time Care again reported another period of consistent trading and growth and we are pleased that our Malaysian team has won another HealthRoster contract, our first national agreement that will see HealthRoster deployed across all public hospitals in Brunei.

 

"In Defence, we are delighted to have closed a major contract extension with the Australian Defence Force ('ADF'). This contract was concluded just after half year end so will be reflected in the second half financials. It extends further the deployment of MAPS in the Australian Army to now join Navy in addressing 100% of its total requirement for MAPS licences and also provides for a substantial number of Civilian staff associated with ADF.

 

"Despite the current environment, I am confident that we remain on track for our full year revenue and profit targets."

 

The Company's results for the half year to 30 November will be released in early February 2012.

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Martin Jeffries - Marketing Director

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Michael Meade / Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

John Bick

Tel :+44 (0) 20 7193 7463

+44 (0) 7525 324 431

 

 

About Allocate Software plc

Allocate Software is the leading workforce and corporate governance software solutions provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include Healthcare and Defence.

 

The experience and in-depth knowledge, gained in the UK and internationally has enabled Allocate to invest in developing innovative solutions that are relevant to the constantly evolving market needs of its customers. At the core of the business is Allocate's workforce optimisation software, which streamlines the whole workforce management of multi disciplinary groups, across diverse locations.

 

Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKFDQNBKBPDK
Date   Source Headline
11th May 20267:00 amRNSElevra to Transfer Ewoyaa Rights and Obligations
7th May 20267:00 amRNSBinding Scheme Implementation Deed with Huayou
30th Apr 20267:00 amRNSQuarterly Activities and Cash Flow Report
20th Mar 20263:00 pmRNSTR-1 Notification of Major Holdings
20th Mar 20267:00 amRNSParliamentary Ratification of Ewoyaa Mining Lease
17th Mar 20261:03 pmRNSCorporate Funding Update - Amendment
17th Mar 20267:00 amRNSCorporate Funding Update
17th Mar 20267:00 amRNSCorporate Funding Update
13th Mar 20267:09 amRNSHalf-year Financial Report
13th Mar 20267:09 amRNSHalf-year Financial Report
23rd Feb 20267:00 amRNSCorporate Update
19th Feb 20268:27 amRNSASX Trading Halt
29th Jan 20267:00 amRNSQuarterly Activities and Cash Flow Report
22nd Dec 20257:00 amRNSRatification Process - Ewoyaa Mining Lease
22nd Dec 20257:00 amRNSRatification Process - Ewoyaa Mining Lease
11th Dec 20257:05 amRNSDirector/PDMR Dealings
11th Dec 20257:00 amRNSUpdate re the Ewoyaa Mining Lease
3rd Dec 20257:00 amRNSTR-1 Notification of Major Holdings
27th Nov 20259:25 amRNSResult of Annual General Meeting
27th Nov 20257:05 amRNSAGM Statement
27th Nov 20257:00 amRNSWithdrawal of AGM Resolution
26th Nov 20257:00 amRNSLong State Funding Update
12th Nov 20257:00 amRNSEwoyaa Lithium Project - Mining Lease Update
6th Nov 202510:07 amRNSResult of Extraordinary General Meeting
31st Oct 20257:00 amRNSQuarterly Activities and Cash Flow Report
28th Oct 20257:00 amRNSNotice of Annual General Meeting
20th Oct 20257:00 amRNSPronounced Lithium-in-soil Anomalies
7th Oct 20257:28 amRNSNotice of Extraordinary General Meeting
11th Sep 20257:00 amRNS2025 Annual Financial Report
9th Sep 20257:00 amRNSTR-1 Notification of Major Holdings
3rd Sep 20257:00 amRNSCorporate Funding Update
31st Jul 20257:00 amRNSQuarterly Activities and Cash Flow Report
18th Jul 20257:00 amRNSEwoyaa Lithium Project - Mining Lease Update
11th Jun 20257:00 amRNSLeadership Streamlining and Cost Reductions
22nd May 20257:00 amRNSSpodumene Pegmatite Discovered in Côte d’Ivoire
19th May 20257:00 amRNSLapse of PDMR Options
30th Apr 20257:00 amRNSQuarterly Activities and Cash Flow Report
24th Apr 202511:56 amRNSResponse to Media Reporting
4th Apr 20257:00 amRNSLapse of PDMR Options
14th Mar 20257:00 amRNSHalf-year Financial Report
4th Feb 20254:06 pmRNSResponse to Press Speculation
30th Jan 20257:15 amRNSQuarterly Activities and Cash Flow Report
30th Jan 20257:00 amRNSUpdated Ewoyaa Feldspar Resource Estimate
24th Jan 20257:00 amRNSResignation of Non-Executive Director
23rd Dec 20247:00 amRNSGrant of Performance Rights
16th Dec 20247:00 amRNSTR-1 Notification of Major Holdings
10th Dec 20247:00 amRNSIssue of Equity
29th Nov 20247:51 amRNSResult of AGM
29th Nov 20247:00 amRNSAGM Statement
26th Nov 20247:00 amRNSStatement re Proposed Merger of PLL and SYA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.